加拿大血液制品,包括用基因重组及用单采术获得的血浆制成的制品,都作为生物制品来管理。血液制品必须得到国家卫生部生物制品管理局的批准方可生产;全血的采集则由加拿大红十字会输血服务部负责管理。自从1978年颁发单采许可证以来,管理局正在计划与红十字会合作对整个的采血工作施行许可证制。生产执照颁发及更换生产执照是由管理局定期组织有经 Canadian blood products, including those prepared by genetic modification and plasma obtained by apheresis, are all administered as biological products. Blood products must be approved by the National Institutes of Health for Biological Products; whole blood collection is managed by the Canadian Red Cross Blood Transfusion Service. Since the single-issue permit was issued in 1978, the Authority is planning to work with the Red Cross to license the entire blood collection. Production licenses issued and replaced by the production license is regularly organized by the Authority